Login Register Cart 0
Generic placeholder image

Current Alzheimer Research

Editor-in-Chief

ISSN (Print): 1567-2050
ISSN (Online): 1875-5828

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe Translate in Chinese
General Research Article

HMPAO-SPECT Can Discriminate between Patients with Subjective Cognitive Complaints with and without Cognitive Deficits and those with Mild Cognitive Impairment

Author(s): F. Rossini*, H. Zauner*, J. Bergmann, M. Kronbichler, I. Spindler, S. Golaszewski, E. Trinka and W. Staffen

Volume 16, Issue 9, 2019

Page: [843 - 851] Pages: 9

DOI: 10.2174/1567205016666190827115138

Price: $65

Abstract

Background: Growing evidence suggests that pathological processes leading to Alzheimer’s disease occurs gradually and begins to develop decades before the earliest clinical symptoms occur. The use of biomarkers has been proposed to detect evidence of preclinical Alzheimer’s pathologic change in asymptomatic subjects. Subjective cognitive complaints (SCC) i.e. self-reported cognitive decline with normal cognition have been reported as an indicator of future cognitive decline, however, this condition is unspecific.

Objective: In the present study we used the regional brain perfusion measured by HMPAO-SPECT as Biomarker of neurodegeneration to compare the regional brain perfusion of patient with subjective cognitive complaints with and without minimal cognitive dysfunction (SCC+ and SCC- respectively) in respect to patients with mild cognitive impairment (MCI).

Methods: We retrospectively examined 736 Patients who referred to our Memory Clinic because of suspected cognitive dysfunction. After exclusion of patients with overt dementia, automated, quantitatively assessed relative cerebral blood flow of 10 forebrain regions (thalamus, parietotemporal, medial temporal, posterior temporal, posterior cingulate gyrus, each region left hemispheric and right hemispheric) and neuropsychological assessment of 64 SCC (32 SCC+; 32 SCC-) and 28 MCI subjects were analysed.

Results:.The most relevant differences between groups in cognitive performance concerned verbal memory. Left hemispheric medial temporal region could significantly discriminate between all three groups, with a progressive decrease n perfusion from SCC towards MCI. Area under the curve of left medial temporal region showed a sensitivity of 0,61 and a specificity of 0,78 for discriminating MCI from SCC.

Conclusion: Automated analysis of HMPAO-SPECT data of MCI and SCC+ patients showed significant perfusion differences in medial temporal region and impaired verbal memory, both of which are known features of Alzheimer’s disease. Perfusion patterns and verbal memory performance in SCC+ are more similar to MCI than SCC-.

Thus, SPECT analysis could distinguish those subjects whose perfusion pattern resembles that of an MCI from those who do not. In our opinion, this could identify two populations with a different risk of progression to AD, with SCC+ subjects needing further diagnostic examination and repeated follow-up.

Keywords: SPECT, SCC, Biomarker, Nuclear Imaging, MCI, Alzheimer.

« Previous Next »
[1]
Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, et al. Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade. Lancet Neurol 9(1): 119-28. (2010).
[http://dx.doi.org/10.1016/S1474-4422(09)70299-6] [PMID: 20083042]
[2]
Reisberg B, Ferris SH, de Leon MJ, Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 139(9): 1136-9. (1982).
[http://dx.doi.org/10.1176/ajp.139.9.1136] [PMID: 7114305]
[3]
Geerlings MI, Jonker C, Bouter LM, Adèr HJ, Schmand B. Association between memory complaints and incident Alzheimer’s disease in elderly people with normal baseline cognition. Am J Psychiatry 156(4): 531-7. (1999).
[PMID: 10200730]
[4]
Jonker C, Geerlings MI, Schmand B. Are memory complaints predictive for dementia? A review of clinical and population-based studies. Int J Geriatr Psychiatry 15(11): 983-91. (2000).
[http://dx.doi.org/10.1002/1099-1166(200011)15:11<983:AID-GPS238>3.0.CO;2-5] [PMID: 11113976]
[5]
Jessen F, Wiese B, Bachmann C, Eifflaender-Gorfer S, Haller F, Kölsch H, et al. Prediction of dementia by subjective memory impairment: effects of severity and temporal association with cognitive impairment. Arch Gen Psychiatry 67(4): 414-22. (2010).
[http://dx.doi.org/10.1001/archgenpsychiatry.2010.30] [PMID: 20368517]
[6]
Hohman TJ, Beason-Held LL, Lamar M, Resnick SM. Subjective cognitive complaints and longitudinal changes in memory and brain function. Neuropsychology 2011; 25(1): 125-30.
[http://dx.doi.org/10.1037/a0020859] [PMID: 20919769]
[7]
Verdelho A, Madureira S, Moleiro C, Santos CO, Ferro JM, Erkinjuntti T, et al. Self-perceived memory complaints predict progression to Alzheimer disease. The LADIS study. J Alzheimers Dis 27(3): 491-8. (2011).
[http://dx.doi.org/10.3233/JAD-2011-110494] [PMID: 21841255]
[8]
Waldorff FB, Siersma V, Vogel A, Waldemar G. Subjective memory complaints in general practice predicts future dementia: a 4-year follow-up study. Int J Geriatr Psychiatry 27(11): 1180-8. (2012).
[http://dx.doi.org/10.1002/gps.3765] [PMID: 22253004]
[9]
Jessen F, Amariglio RE, van Boxtel M, Breteler M, Ceccaldi M, Chételat G, et al. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimers Dement 10(6): 844-52. (2014).
[http://dx.doi.org/10.1016/j.jalz.2014.01.001] [PMID: 24798886]
[10]
Stewart R. Subjective cognitive impairment. Curr Opin Psychiatry 25(6): 445-50. (2012).
[http://dx.doi.org/10.1097/YCO.0b013e3283586fd8] [PMID: 23037961]
[11]
Sun Y, Yang FC, Lin CP, Han Y. Biochemical and neuroimaging studies in subjective cognitive decline: progress and perspectives. CNS Neurosci Ther 21(10): 768-75. (2015).
[http://dx.doi.org/10.1111/cns.12395] [PMID: 25864576]
[12]
Wicklund M, Petersen RC. Emerging biomarkers in cognition. Clin Geriatr Med 29(4): 809-28. (2013).
[http://dx.doi.org/10.1016/j.cger.2013.07.006] [PMID: 24094298]
[13]
Hirao K, Ohnishi T, Hirata Y, Yamashita F, Mori T, Moriguchi Y, et al. The prediction of rapid conversion to Alzheimer’s disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage 2005; 28(4): 1014-21.
[http://dx.doi.org/10.1016/j.neuroimage.2005.06.066] [PMID: 16129627]
[14]
Borroni B, Anchisi D, Paghera B, Vicini B, Kerrouche N, Garibotto V, et al. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging 27(1): 24-31. (2006).
[http://dx.doi.org/10.1016/j.neurobiolaging.2004.12.010] [PMID: 16298237]
[15]
Nobili F, Frisoni GB, Portet F, Verhey F, Rodriguez G, Caroli A, et al. Brain SPECT in subtypes of mild cognitive impairment. Findings from the DESCRIPA multicenter study. J Neurol 255(9): 1344-53. (2008).
[http://dx.doi.org/10.1007/s00415-008-0897-4] [PMID: 18958573]
[16]
Staffen W, Bergmann J, Schönauer U, Zauner H, Kronbichler M, Golaszewski S, et al. Cerebral perfusion (HMPAO-SPECT) in patients with depression with cognitive impairment versus those with mild cognitive impairment and dementia of Alzheimer’s type: a semiquantitative and automated evaluation. Eur J Nucl Med Mol Imaging 36(5): 801-10. (2009).
[http://dx.doi.org/10.1007/s00259-008-1028-2] [PMID: 19137294]
[17]
Banzo I, Quirce R, Martínez-Rodríguez I, et al. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan] Rev Esp Med Nucl 30(5): 301-6. (2011).
[http://dx.doi.org/10.1016/j.remngl.2011.03.011] [PMID: 21640440]
[18]
Jobst KA, Barnetson LP, Shepstone BJ. Accurate prediction of histologically confirmed Alzheimer’s disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging. Int Psychogeriatr 10(3): 271-302. (1998).
[http://dx.doi.org/10.1017/S1041610298005389] [PMID: 9785148]
[19]
Fleming JS, Kemp PM, Bolt L, Goatman KA. Measurement of cerebral perfusion volume and 99mTc-HMPAO uptake using SPECT in controls and patients with Alzheimer’s disease. Nucl Med Commun 23(11): 1057-64. (2002).
[http://dx.doi.org/10.1097/00006231-200211000-00004] [PMID: 12411833]
[20]
Van Laere KJ, Warwick J, Versijpt J, Goethals I, Audenaert K, Van Heerden B, et al. Analysis of clinical brain SPECT data based on anatomic standardization and reference to normal data: an ROC-based comparison of visual, semiquantitative, and voxel-based methods. J Nucl Med 43(4): 458-69. (2002).
[PMID: 11937588]
[21]
Staffen W, Schönauer U, Zauner H, Spindler I, Mair A, Iglseder B, et al. Brain perfusion SPECT in patients with mild cognitive impairment and Alzheimer’s disease: comparison of a semiquantitative and a visual evaluation. J Neural Transm (Vienna) 113(2): 195-203. (2006).
[http://dx.doi.org/10.1007/s00702-005-0321-5] [PMID: 15959843]
[22]
Høgh P, Teller AS, Hasselbalch S, Waldemar G. Visual rating and ROI-based parametric analysis of rCBF SPECT in patients with mild or questionable dementia: a comparative study. Dement Geriatr Cogn Disord 24(6): 429-33. (2007).
[http://dx.doi.org/10.1159/000110023] [PMID: 17952007]
[23]
Matsuda H, Mizumura S, Nagao T, Ota T, Iizuka T, Nemoto K, et al. Automated discrimination between very early Alzheimer disease and controls using an easy Z-score imaging system for multicenter brain perfusion single-photon emission tomography. AJNR Am J Neuroradiol 28(4): 731-6. (2007).
[PMID: 17416830]
[24]
Habert MO, Horn JF, Sarazin M, Lotterie JA, Puel M, Onen F, et al. Brain perfusion SPECT with an automated quantitative tool can identify prodromal Alzheimer’s disease among patients with mild cognitive impairment. Neurobiol Aging 32(1): 15-23. (2011).
[http://dx.doi.org/10.1016/j.neurobiolaging.2009.01.013] [PMID: 19250707]
[25]
Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, et al. Current concepts in mild cognitive impairment. Arch Neurol 58(12): 1985-92. (2001).
[http://dx.doi.org/10.1001/archneur.58.12.1985] [PMID: 11735772]
[26]
Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3): 189-98. (1975).
[http://dx.doi.org/10.1016/0022-3956(75)90026-6] [PMID: 1202204]
[27]
Wechsler D. A standardized memory scale for clinical use. J Psychol 19: 87-95. (1945).
[http://dx.doi.org/10.1080/00223980.1945.9917223]
[28]
Dahl G. Reduzierter Wechsler-Intelligenztest (1986).
[29]
Baxa W, Pakesch E. Mitteilung über die Verwendung eines Index am HAWIE zur Bestimmung einer sekundären Intelligenzreduzierung. Wien Z Nervenheilkd 30: 119-30. (1972).
[30]
Lehrl S, Merz J, Burkhard G, Fischer S. Mehrfachwahl-Wortschatz-Intelligenztest Spitta Verlag (2005).
[31]
Oswald WD, Fleischmann UM. Das Nürnberger-Alters-Inventar (1997).
[32]
Zung WWK. Depressions-Status-Inventar (DSI) Fremdbeurteilungsskala. (1986).
[33]
Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nucl Sci 21: 2-20. (1978).
[http://dx.doi.org/10.1109/TNS.1978.4329385]
[34]
Kanetaka H, Matsuda H, Asada T, Ohnishi T, Yamashita F, Imabayashi E, et al. Effects of partial volume correction on discrimination between very early Alzheimer’s dementia and controls using brain perfusion SPECT. Eur J Nucl Med Mol Imaging 31(7): 975-80. (2004).
[http://dx.doi.org/10.1007/s00259-004-1491-3] [PMID: 14991240]
[35]
Jessen F, Wiese B, Cvetanovska G, Fuchs A, Kaduszkiewicz H, Kölsch H, et al. Patterns of subjective memory impairment in the elderly: association with memory performance. Psychol Med 37(12): 1753-62. (2007).
[http://dx.doi.org/10.1017/S0033291707001122] [PMID: 17623488]
[36]
Clarnette RM, Almeida OP, Forstl H, Paton A, Martins RN. Clinical characteristics of individuals with subjective memory loss in Western Australia: results from a cross-sectional survey. Int J Geriatr Psychiatry 16(2): 168-74. (2001).
[http://dx.doi.org/10.1002/1099-1166(200102)16:2<168:AID-GPS291>3.0.CO;2-D] [PMID: 11241722]
[37]
Pires C, Silva D, Maroco J, Ginó S, Mendes T, Schmand BA, et al. Memory complaints associated with seeking clinical care [Published online 2012 Mar 24.];2012 https://www.hindawi.com/journals/ijad/2012/725329/
[http://dx.doi.org/10.1155/2012/725329]
[38]
Barker A, Jones R, Jennison C. A prevalence study of age-associated memory impairment. Br J Psychiatry 167(5): 642-8. (1995).
[http://dx.doi.org/10.1192/bjp.167.5.642] [PMID: 8564321]
[39]
Jonker C, Launer LJ, Hooijer C, Lindeboom J. Memory complaints and memory impairment in older individuals. J Am Geriatr Soc 44(1): 44-9. (1996).
[http://dx.doi.org/10.1111/j.1532-5415.1996.tb05636.x] [PMID: 8537589]
[40]
Bassett SS, Folstein MF. Memory complaint, memory performance, and psychiatric diagnosis: a community study. J Geriatr Psychiatry Neurol 6(2): 105-11. (1993).
[http://dx.doi.org/10.1177/089198879300600207] [PMID: 8512626]
[41]
Gagnon M, Dartigues JF, Mazaux JM, Dequae L, Letenneur L, Giroire JM, et al. Self-reported memory complaints and memory performance in elderly French community residents: results of the PAQUID Research Program. Neuroepidemiology 13(4): 145-54. (1994).
[http://dx.doi.org/10.1159/000110373] [PMID: 8090256]
[42]
Schofield PW, Marder K, Dooneief G, Jacobs DM, Sano M, Stern Y. Association of subjective memory complaints with subsequent cognitive decline in community-dwelling elderly individuals with baseline cognitive impairment. Am J Psychiatry 154(5): 609-15. (1997).
[http://dx.doi.org/10.1176/ajp.154.5.609] [PMID: 9137114]
[43]
Erk S, Spottke A, Meisen A, Wagner M, Walter H, Jessen F. Evidence of neuronal compensation during episodic memory in subjective memory impairment. Arch Gen Psychiatry 68(8): 845-52. (2011).
[http://dx.doi.org/10.1001/archgenpsychiatry.2011.80] [PMID: 21810648]
[44]
Rodda J, Dannhauser T, Cutinha DJ, Shergill SS, Walker Z. Subjective cognitive impairment: functional MRI during a divided attention task. Eur Psychiatry 26(7): 457-62. (2011).
[http://dx.doi.org/10.1016/j.eurpsy.2010.07.003] [PMID: 20932721]
[45]
Frisoni GB, Bocchetta M, Chételat G, Rabinovici GD, de Leon MJ, Kaye J, et al. Imaging markers for Alzheimer disease: which vs how. Neurology 81(5): 487-500. (2013).
[http://dx.doi.org/10.1212/WNL.0b013e31829d86e8] [PMID: 23897875]
[46]
Caroli A, Testa C, Geroldi C, Nobili F, Barnden LR, Guerra UP, et al. Cerebral perfusion correlates of conversion to Alzheimer’s disease in amnestic mild cognitive impairment. J Neurol 254(12): 1698-707. (2007).
[http://dx.doi.org/10.1007/s00415-007-0631-7] [PMID: 17990057]
[47]
Johnson KA, Moran EK, Becker JA, Blacker D, Fischman AJ, Albert MS. Single photon emission computed tomography perfusion differences in mild cognitive impairment. J Neurol Neurosurg Psychiatry 78(3): 240-7. (2007).
[http://dx.doi.org/10.1136/jnnp.2006.096800] [PMID: 17056633]
[48]
Alegret M, Cuberas-Borrós G, Vinyes-Junqué G, Espinosa A, Valero S, Hernández I, et al. A two-year follow-up of cognitive deficits and brain perfusion in mild cognitive impairment and mild Alzheimer’s disease. J Alzheimers Dis 2012; 30(1): 109-20.
[http://dx.doi.org/10.3233/JAD-2012-111850] [PMID: 22406443]
[49]
Alegret M, Cuberas-Borrós G, Espinosa A, Valero S, Hernández I, Ruíz A, et al. Cognitive, genetic, and brain perfusion factors associated with four year incidence of Alzheimer’s disease from mild cognitive impairment. J Alzheimers Dis 41(3): 739-48. (2014).
[http://dx.doi.org/10.3233/JAD-132516] [PMID: 24685632]
[50]
Merrill DA, Siddarth P, Saito NY, Ercoli LM, Burggren AC, Kepe V, et al. Self-reported memory impairment and brain PET of amyloid and tau in middle-aged and older adults without dementia. Int Psychogeriatr 24(7): 1076-84. (2012).
[http://dx.doi.org/10.1017/S1041610212000051] [PMID: 22335970]
[51]
Perrotin A, Mormino EC, Madison CM, Hayenga AO, Jagust WJ. Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals. Arch Neurol 69(2): 223-9. (2012).
[http://dx.doi.org/10.1001/archneurol.2011.666] [PMID: 22332189]
[52]
Stewart R, Dufouil C, Godin O, Ritchie K, Maillard P, Delcroix N, et al. Neuroimaging correlates of subjective memory deficits in a community population. Neurology 70(18): 1601-7. (2008).
[http://dx.doi.org/10.1212/01.wnl.0000310982.99438.54] [PMID: 18443310]
[53]
Braak H, Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82(4): 239-59. (1991).
[http://dx.doi.org/10.1007/BF00308809] [PMID: 1759558]
[54]
Nobili F, Brugnolo A, Calvini P, Copello F, De Leo C, Girtler N, et al. Resting SPECT-neuropsychology correlation in very mild Alzheimer’s disease. Clin Neurophysiol 2005; 116(2): 364-75.
[http://dx.doi.org/10.1016/j.clinph.2004.09.001] [PMID: 15661114]
[55]
Kidron D, Black SE, Stanchev P, Buck B, Szalai JP, Parker J, et al. Quantitative MR volumetry in Alzheimer’s disease. Topographic markers and the effects of sex and education. Neurology 49(6): 1504-12. (1997).
[http://dx.doi.org/10.1212/WNL.49.6.1504] [PMID: 9409337]
[56]
Yamaguchi S, Meguro K, Itoh M, Hayasaka C, Shimada M, Yamazaki H, et al. Decreased cortical glucose metabolism correlates with hippocampal atrophy in Alzheimer’s disease as shown by MRI and PET. J Neurol Neurosurg Psychiatry 62(6): 596-600. (1997).
[http://dx.doi.org/10.1136/jnnp.62.6.596] [PMID: 9219745]
[57]
Bradley KM, O’Sullivan VT, Soper NDW, Nagy Z, King EM, Smith AD, et al. Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer’s disease. Brain 125(Pt 8): 1772-81. (2002).
[http://dx.doi.org/10.1093/brain/awf185] [PMID: 12135968]
[58]
Höller Y, Bathke AC, Uhl A, Strobl N, Lang A, Bergmann J, et al. Combining SPECT and Quantitative EEG Analysis for the Automated Differential Diagnosis of Disorders with Amnestic Symptoms Front Aging Neurosci 2017 [Published online 2017 Sep 7] https://www.frontiersin.org/articles/10.3389/fnagi.2017.00290/full
[http://dx.doi.org/10.3389/fnagi.2017.00290]

Rights & Permissions Print Cite
Article Metrics
38
4
1
© 2024 Bentham Science Publishers | Privacy Policy